- On November 17, the FDA updated its Leafy Green STEC Action Plan (LGAP). FDA first released the LGAP in 2020 following recurring outbreaks linked to leafy greens caused by
Leafy Greens
FDA Announces 2022 Leafy Green Sampling
Posted on
- On September 8, 2022, FDA announced that it was performing targeted sampling of leafy greens as part of its Leafy Greens STEC Action Plan (LGAP). Specifically, FDA is sampling
FDA Releases Report on 2021 Leafy Greens Outbreak
Posted on
- On January 14, 2022, FDA released a report on the investigation into the Summer 2021 outbreak of Salmonella Typhimurium associated with the consumption of packaged leafy greens. The investigation found
…
Continue Reading FDA Releases Report on 2021 Leafy Greens Outbreak
FDA Releases Investigation Report on Fall 2020 Leafy Green E. coli Outbreak
Posted on
- On April 6, the FDA released a report on the investigation into the Fall 2020 outbreak of E. coli O157:H7 illnesses linked to the consumption of leafy greens. Through the
…
Continue Reading FDA Releases Investigation Report on Fall 2020 Leafy Green E. coli Outbreak
FDA Launches Study of Foodborne Pathogens in Partnership with Californian Stakeholders
Posted on
- On November 19, 2020, the FDA announced that it was partnering with the California Department of Food and Agriculture (CDFA), the University of California, Davis, Western Center for Food Safety